PoliticalRepoPoliticalRepo

Ireland · Question · written

PQ 524

524. Deputy Sean Fleming asked the Minister for Health the current position regarding the reimbursement of Orkambi for persons with cystic fibrosis; if the full health technology assessment by the National Centre for Pharmacoeconomics has been completed; if a report has been submitted to the HSE for consideration on this matter; and if he will make a statement on the matter. [30871/16]

askedIreland· Dáil Éireann· EN

Introduced

18 October 2016

Last action

18 October 2016 · Medicinal Products Reimbursement

Status

written

Sponsors

Sean Fleming

Subjects

Discovery layer

Source updated

18 October 2016

Summary

524. Deputy Sean Fleming asked the Minister for Health the current position regarding the reimbursement of Orkambi for persons with cystic fibrosis; if the full health technology assessment by the National Centre for Pharmacoeconomics has been completed; if a report has been submitted to the HSE for consideration on this matter; and if he will make a statement on the matter. [30871/16]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 18 October 2016

    Medicinal Products Reimbursement

    524. Deputy Sean Fleming asked the Minister for Health the current position regarding the reimbursement of Orkambi for persons with cystic fibrosis; if the full health technology assessment by the National Centre for Pharmacoeconomics has been completed; if a report has been submitted to the HSE for consideration on this matter; and if he will make a statement on the matter. [30871/16]

    Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Medicinal Products Reimbursement

View fileDownload file

Sponsors

  • Sean Fleming · Asking member
  • Health · Health · Addressed to

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.